Which has better valuation & earnings, ITGR or HQY?

HealthEquity has lower revenue, but higher earnings than Integer. HealthEquity is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.32 $102.81M $3.66 34.52 HealthEquity $1.31B 5.49 $215.20M $2.77 31.50

Is ITGR or HQY more profitable?

HealthEquity has a net margin of 17.36% compared to Integer's net margin of 6.97%. HealthEquity's return on equity of 15.33% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets Integer 6.97% 12.79% 6.48% HealthEquity 17.36% 15.33% 9.51%

HealthEquity (HQY) Competitors

$87.25 -1.19 (-1.35%)

Closing price 04:00 PM Eastern

Extended Trading

$87.23 -0.02 (-0.02%)

As of 04:15 PM Eastern

Compare

HQY vs. ITGR, MOH, OSCR, CLOV, and ALHC

Should you buy HealthEquity stock or one of its competitors? HealthEquity's main competitors and comparable companies include Integer (ITGR), Molina Healthcare (MOH), Oscar Health (OSCR), Clover Health Investments (CLOV), and Alignment Healthcare (ALHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does HealthEquity compare to Integer?

Integer (NYSE:ITGR) and HealthEquity (NASDAQ:HQY) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

HealthEquity has a net margin of 17.36% compared to Integer's net margin of 6.97%. HealthEquity's return on equity of 15.33% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
HealthEquity	17.36%	15.33%	9.51%

Integer presently has a consensus price target of $109.86, suggesting a potential downside of 13.05%. HealthEquity has a consensus price target of $112.20, suggesting a potential upside of 28.60%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92

In the previous week, Integer had 2 more articles in the media than HealthEquity. MarketBeat recorded 3 mentions for Integer and 1 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.83 beat Integer's score of 0.17 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Overall Sentiment
Integer	Neutral
HealthEquity	Positive

Integer has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

99.3% of Integer shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

HealthEquity has lower revenue, but higher earnings than Integer. HealthEquity is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$3.66	34.52
HealthEquity	$1.31B	5.49	$215.20M	$2.77	31.50

Summary

HealthEquity beats Integer on 12 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Molina Healthcare?

HealthEquity (NASDAQ:HQY) and Molina Healthcare (NYSE:MOH) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

Molina Healthcare has higher revenue and earnings than HealthEquity. Molina Healthcare is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.49	$215.20M	$2.77	31.50
Molina Healthcare	$45.43B	0.22	$472M	-$0.18	N/A

HealthEquity currently has a consensus target price of $112.20, indicating a potential upside of 28.60%. Molina Healthcare has a consensus target price of $202.44, indicating a potential upside of 6.82%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.18

HealthEquity has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.75, suggesting that its share price is 25% less volatile than the broader market.

In the previous week, Molina Healthcare had 4 more articles in the media than HealthEquity. MarketBeat recorded 5 mentions for Molina Healthcare and 1 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.83 beat Molina Healthcare's score of 0.46 indicating that HealthEquity is being referred to more favorably in the media.

Company	Overall Sentiment
HealthEquity	Positive
Molina Healthcare	Neutral

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

HealthEquity has a net margin of 17.36% compared to Molina Healthcare's net margin of -0.02%. HealthEquity's return on equity of 15.33% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Molina Healthcare	-0.02%	3.73%	0.97%

Summary

HealthEquity beats Molina Healthcare on 12 of the 16 factors compared between the two stocks.

How does HealthEquity compare to Oscar Health?

Oscar Health (NYSE:OSCR) and HealthEquity (NASDAQ:HQY) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Oscar Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

75.7% of Oscar Health shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 22.6% of Oscar Health shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

HealthEquity has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oscar Health	$11.70B	0.78	-$443.15M	$1.40	21.24
HealthEquity	$1.31B	5.49	$215.20M	$2.77	31.50

In the previous week, Oscar Health had 9 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for Oscar Health and 1 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.83 beat Oscar Health's score of 0.66 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Overall Sentiment
Oscar Health	Positive
HealthEquity	Positive

Oscar Health presently has a consensus target price of $33.90, indicating a potential upside of 14.03%. HealthEquity has a consensus target price of $112.20, indicating a potential upside of 28.60%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oscar Health	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.31
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92

HealthEquity has a net margin of 17.36% compared to Oscar Health's net margin of 3.60%. Oscar Health's return on equity of 38.45% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oscar Health	3.60%	38.45%	6.76%
HealthEquity	17.36%	15.33%	9.51%

Summary

HealthEquity beats Oscar Health on 11 of the 16 factors compared between the two stocks.

How does HealthEquity compare to Clover Health Investments?

HealthEquity (NASDAQ:HQY) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

In the previous week, Clover Health Investments had 7 more articles in the media than HealthEquity. MarketBeat recorded 8 mentions for Clover Health Investments and 1 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.83 beat Clover Health Investments' score of 0.49 indicating that HealthEquity is being referred to more favorably in the media.

Company	Overall Sentiment
HealthEquity	Positive
Clover Health Investments	Neutral

HealthEquity currently has a consensus price target of $112.20, suggesting a potential upside of 28.60%. Clover Health Investments has a consensus price target of $4.75, suggesting a potential upside of 9.95%. Given HealthEquity's stronger consensus rating and higher probable upside, equities research analysts clearly believe HealthEquity is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

HealthEquity has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.49	$215.20M	$2.77	31.50
Clover Health Investments	$1.92B	1.19	-$85.55M	-$0.05	N/A

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

HealthEquity has a net margin of 17.36% compared to Clover Health Investments' net margin of -0.74%. HealthEquity's return on equity of 15.33% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Clover Health Investments	-0.74%	-4.20%	-2.28%

HealthEquity has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, meaning that its stock price is 147% more volatile than the broader market.

Summary

HealthEquity beats Clover Health Investments on 13 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Alignment Healthcare?

Alignment Healthcare (NASDAQ:ALHC) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

Alignment Healthcare has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

In the previous week, Alignment Healthcare had 2 more articles in the media than HealthEquity. MarketBeat recorded 3 mentions for Alignment Healthcare and 1 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.83 beat Alignment Healthcare's score of 0.29 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Overall Sentiment
Alignment Healthcare	Neutral
HealthEquity	Positive

HealthEquity has lower revenue, but higher earnings than Alignment Healthcare. HealthEquity is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alignment Healthcare	$3.95B	0.42	-$720K	$0.19	41.63
HealthEquity	$1.31B	5.49	$215.20M	$2.77	31.50

HealthEquity has a net margin of 17.36% compared to Alignment Healthcare's net margin of 0.89%. Alignment Healthcare's return on equity of 20.02% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alignment Healthcare	0.89%	20.02%	3.46%
HealthEquity	17.36%	15.33%	9.51%

86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by company insiders. Comparatively, 1.6% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alignment Healthcare presently has a consensus target price of $23.60, indicating a potential upside of 198.36%. HealthEquity has a consensus target price of $112.20, indicating a potential upside of 28.60%. Given Alignment Healthcare's higher possible upside, equities research analysts clearly believe Alignment Healthcare is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alignment Healthcare	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92

Summary

HealthEquity beats Alignment Healthcare on 10 of the 17 factors compared between the two stocks.

Get HealthEquity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQY vs. The Competition

Export

Metric	HealthEquity	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$7.22B	$9.70B	$7.26B	$13.03B
Dividend Yield	N/A	2.59%	2.52%	14.03%
P/E Ratio	31.50	34.69	274.72	25.67
Price / Sales	5.49	5.00	606.70	80.64
Price / Cash	16.73	24.19	28.02	35.00
Price / Book	3.54	5.17	10.49	6.43
Net Income	$215.20M	$315.68M	$3.50B	$360.21M
7 Day Performance	-4.90%	-2.55%	-3.03%	-2.83%
1 Month Performance	-9.46%	-0.99%	-4.16%	-4.08%
1 Year Performance	-8.49%	12.69%	13.20%	3.84%

HealthEquity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQY HealthEquity	4.3186 of 5 stars	$87.25 -1.3%	$112.20 +28.6%	-8.4%	$7.22B	$1.31B	31.50	2,814
ITGR Integer	2.2211 of 5 stars	$126.42 +0.1%	$109.86 -13.1%	+24.4%	$4.29B	$1.85B	34.54	11,000
MOH Molina Healthcare	1.8885 of 5 stars	$197.70 -1.5%	$202.44 +2.4%	-1.6%	$10.48B	$45.43B	N/A	19,000	Positive News Analyst Upgrade
OSCR Oscar Health	4.6475 of 5 stars	$31.32 -2.5%	$33.90 +8.2%	+61.3%	$9.92B	$11.70B	22.37	2,305
CLOV Clover Health Investments	2.8072 of 5 stars	$4.54 +1.8%	$4.75 +4.6%	+35.3%	$2.37B	$1.92B	N/A	724

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HQY) was last updated on 9/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthEquity (HQY) Competitors

HQY vs. ITGR, MOH, OSCR, CLOV, and ALHC

How does HealthEquity compare to Integer?

Summary

How does HealthEquity compare to Molina Healthcare?

Summary

How does HealthEquity compare to Oscar Health?

Summary

How does HealthEquity compare to Clover Health Investments?

Summary

How does HealthEquity compare to Alignment Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HealthEquity (HQY) Competitors

HQY vs. ITGR, MOH, OSCR, CLOV, and ALHC

How does HealthEquity compare to Integer?

Is ITGR or HQY more profitable?

Do analysts prefer ITGR or HQY?

Does the media favor ITGR or HQY?

Which has more volatility and risk, ITGR or HQY?

Do insiders and institutionals hold more shares of ITGR or HQY?

Which has better valuation & earnings, ITGR or HQY?

Summary

How does HealthEquity compare to Molina Healthcare?

Which has preferable valuation and earnings, HQY or MOH?

Do analysts prefer HQY or MOH?

Which has more volatility & risk, HQY or MOH?

Does the media refer more to HQY or MOH?

Do insiders & institutionals have more ownership in HQY or MOH?

Is HQY or MOH more profitable?

Summary

How does HealthEquity compare to Oscar Health?

Which has more risk & volatility, OSCR or HQY?

Do insiders & institutionals believe in OSCR or HQY?

Which has preferable earnings & valuation, OSCR or HQY?

Does the media favor OSCR or HQY?

Do analysts prefer OSCR or HQY?

Is OSCR or HQY more profitable?

Summary

How does HealthEquity compare to Clover Health Investments?

Does the media refer more to HQY or CLOV?

Do analysts recommend HQY or CLOV?

Which has higher earnings and valuation, HQY or CLOV?

Do insiders and institutionals hold more shares of HQY or CLOV?

Is HQY or CLOV more profitable?

Which has more risk & volatility, HQY or CLOV?

Summary

How does HealthEquity compare to Alignment Healthcare?

Which has more volatility and risk, ALHC or HQY?

Does the media prefer ALHC or HQY?

Which has preferable valuation & earnings, ALHC or HQY?

Is ALHC or HQY more profitable?

Do insiders & institutionals believe in ALHC or HQY?

Do analysts rate ALHC or HQY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools